Citius Pharmaceuticals Inc. (CTXR)
Citius Oncology - Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
Citius Oncology - Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome
CyncHealth Nebraska Expands Partnership with Health Catalyst to Accelerate Measurable Improvement in Nebraska
Teva Pharmaceutical Industries Ltd. - Teva’sEmrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
Biomerica, Inc. - Biomerica Launches AI-BackedinFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes